Clinical Characteristics and Histologic Features of Hysterectomy Specimens From Transmasculine Individuals
- PMID: 34259463
- DOI: 10.1097/AOG.0000000000004421
Clinical Characteristics and Histologic Features of Hysterectomy Specimens From Transmasculine Individuals
Abstract
Objective: To describe the clinical characteristics of transmasculine individuals who underwent hysterectomy and characterize surgical pathology findings.
Methods: Under an institutional review board-approved protocol, transmasculine individuals who were undergoing hysterectomy and bilateral salpingectomy or bilateral salpingo-oophorectomy were retrospectively identified from a single institution. Past medical, surgical, obstetric, and gynecologic history were collected, including prior testosterone use, cervical cancer screening status, and preoperative pelvic imaging. Surgical pathologic findings of the endometrium, ovaries, and cervix were collected.
Results: A total of 72 individuals were included. The median age was 30 years (range 19-51). The majority of patients had private insurance (n=53, 74%) and were on testosterone at time of the preoperative visit (n=63, 88%). Forty-two patients (58%) reported anxiety, depression, or bipolar disorder, and 34 patients (47%) were taking an antidepressant or mood stabilizer. Of the 68 patients eligible for cervical cancer screening, 33 (49%) were up to date before their surgical consultation visits. Pelvic pain was the leading indication for surgery (n=65, 90%), and 29 patients (40%) had multiple listed indications for surgery. Surgical pathology results included cervical intraepithelial neoplasia 2-3 in three patients (4%), endometrial or cervical atrophy in 13 patients (18%), and ovarian or paratubal cysts in 16 patients (22%).
Conclusion: This study describes the distinct clinical characteristics and surgical pathology findings that health care professionals should consider when caring for this unique patient population, including a relatively high rate of mental health conditions, pelvic pain as the leading indication for surgery, and the presence of endometrial or cervical atrophy and ovarian or paratubal cysts on surgical pathology.
Copyright © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Financial Disclosure The authors did not report any potential conflicts of interest.
References
-
- Institute of Medicine. The health of lesbian, gay, bisexual, and transgender people: building a foundation for better understanding. The National Academies Press; 2011
-
- Grimstad FW, Fowler KG, New EP, Ferrando CA, Pollard RR, Chapman G, et al. Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series. Am J Obstet Gynecol 2019;220:257.e1–7. doi: 10.1016/j.ajog.2018.12.021 - DOI
-
- Khalifa MA, Toyama A, Klein ME, Santiago V. Histologic features of hysterectomy specimens from female-male transgender individuals. Int J Gynecol Pathol 2019;38:520–7. doi: 10.1097/PGP.0000000000000548 - DOI
-
- Singh K, Sung CJ, Lawrence WD, Quddus MR. Testosterone-induced “virilization” of mesonephric duct remnants and cervical squamous epithelium in female-to-male transgenders: a report of 3 cases. Int J Gynecol Pathol 2017;36:328–33. doi: 10.1097/PGP.0000000000000333 - DOI
-
- Bretschneider CE, Sheyn D, Pollard R, Ferrando CA. Complication rates and outcomes after hysterectomy in transgender men. Obstet Gynecol 2018;132:1265–73. doi: 10.1097/AOG.0000000000002936 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
